Chloramphenicol

氯霉素

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameChloramphenicol
Drug Alias Namechloramphenicolum氯丝菌素氯胺苯醇cloranfenicolChloromycetin +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Action50S ribosomal subunit inhibitors
Targets50S ribosomal subunit
Therapy Area/IndicationsKeratitisConjunctivitis, BacterialBacterial Infections
Global Approved IndicationsConjunctivitis, BacterialBacterial Infections
Approved Indications in ChinaBacterial Infections
Original Approved Country/TerritoryCanada
Original Approved Date1951/01/01
Country/TerritoryCanadaUnited StatesUnited Kingdom +[5] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesAlfresa PharmaThe Boots Company PlcWuhan Wuyao Pharmaceutical Co Ltd
Inactive CompaniesParke-Davis GmbhAllergan PlcParkedale Pharmaceuticals, Inc
Active IndicationsConjunctivitis, BacterialBacterial Infections
Inactive IndicationsKeratitis

Other Information

ATC CodeD06AX02D10AF03G01AA05 +[7] 
Related LinksWikipediaDrugBankKEGG